Leftagraph

Every financial statement,
one clean chart.

Search any US-listed company. Data straight from SEC filings.

PROBuild your own list with the screener

ADC Therapeutics SA (ADCT) financial statements

Number look wrong? Tell us

Data table
PROBuild your own list with the screener

ADC Therapeutics SA (ADCT), most recent 12 months reported: revenue $79.58M, net loss $96.91M, free cash flow -$102.3M. Latest balance sheet on file: liquid cash $219.11M. From SEC filings. Others in Pharmaceutical Preparations: Septerna, Inc. · AGIOS PHARMACEUTICALS, INC. · Verastem, Inc. · Standard BioTools Inc. · KURA ONCOLOGY, INC. · Assembly Biosciences, Inc. · Viridian Therapeutics, Inc./DE · ROCKWELL MEDICAL, INC.

Stock screener

Watchlist